Research Site 10001-085 — Manassas, Virginia

Research Site 10001-085 is a clinical research site located in Manassas, Virginia, United States 20110.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site 10001-085 has participated in 2 clinical trials.

Therapeutic areas: ASCVD, Elevated Cholesterol, Heterozygous Familial Hypercholesterolemia.

Sponsors: The Medicines Company, Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Manassas

Browse all research sites in Virginia · View every site in Manassas

• Manassas Clinical Research Center
• Research Site
• GSK Investigational Site
• Carient Heart and Vascular
• Carient Heart & Vascular - Manassas
• Virginia Cancer Specialists, PC
• Novartis Investigative Site
• Manassas Clinical Research
• Gastroenterology Associates, PC
• Carient Heart & Vascular
• Virginia Cancer Specialists
• ISOThrive Inc.

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site 10001-085?

Research Site 10001-085 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site 10001-085 conducted?

Research Site 10001-085 has 2 clinical trials on record. Their work covers ASCVD, Elevated Cholesterol, Heterozygous Familial Hypercholesterolemia.

Is Research Site 10001-085 accredited by Crixeo Clinical Trials?

Research Site 10001-085 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site 10001-085?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.